GCG and metabolic dysfunction-associated steatohepatitis: Recently, another trial assessing the efficacy of dual glucagon and glucagon-like peptide (GLP) agonist, survodutide, interestingly showed improvement in MASH and fibrosis stage in patients with biopsy-confirmed MASH [11].